Changes in the GH/IGF-1 axis are well-documented in cirrhosis, and the peptides involved have been proposed as markers of hepatocellular dysfunction, malnutrition and survival in this category of patients[11, 25, 26]. The gene discussed is GH1; the disease is Cirrhosis.